The Case Against "University of Michigan Health"
A tax-advantaged academic medical center that operates like a corporation, compensates like Wall Street, and pays taxes like a church.
Revenue (FY2025)
$8.5B
University Assets
$35.4B
CEO Salary
$1.64M
Fair Share Deficit
-$92M
340B Contracts
516
Exhibit A
Tax Status
Tax Exemptions: As part of the University of Michigan, a governmental entity, Michigan Medicine is exempt from federal, state, and local taxes, including property taxes. The University of Michigan's tax-exempt status was granted in its 1817 charter — over two centuries of structural tax immunity.
Total Tax Savings: Michigan's nonprofit hospitals receive an estimated $1 billion in tax breaks annually. The average tax break per hospital is $9.5 million.
Property Tax Exemption: The University of Michigan's growing real estate portfolio, much of which is used by Michigan Medicine, removes significant property value from the tax rolls of Ann Arbor and other communities, shifting the tax burden to residents.
Verdict
University of Michigan Health enjoys a state of "structural tax immunity," leveraging its educational and governmental status to avoid taxes at a massive scale, while its operations increasingly resemble a for-profit enterprise.
Exhibit B
Financial Scale
Massive Revenue: Michigan Medicine is projected to generate $8.5 billion in total operating revenue in fiscal year 2025, a significant increase from $7.9 billion in 2024 and $5.9 billion in 2023. This places it among the largest health systems in the country, rivaling many for-profit healthcare giants.
Vast Assets: The University of Michigan as a whole possesses $35.4 billion in total assets, with a net position of $22.3 billion in 2024. Michigan Medicine, as a major component of the university, represents a significant portion of these assets.
Consistent Surpluses: Despite its nonprofit status, Michigan Medicine consistently generates substantial operating surpluses, reporting a $233.5 million operating margin (2.7%) in fiscal year 2025. This surplus is reinvested into further expansion and growth, rather than being returned to the community in the form of lower prices or increased charity care.
Revenue Growth
Verdict
With a financial footprint larger than the GDP of many small countries, University of Michigan Health operates not as a charity, but as a tax-advantaged, multi-billion-dollar corporation focused on market dominance and revenue growth.
Exhibit C
Executive Compensation
Lavish Executive Pay: The leaders of this "nonprofit" health system are compensated at levels that rival or exceed their for-profit counterparts. CEO Marschall Runge received a salary of $1.64 million in 2023. COO Charles Reuland earns $1.16 million.
Compensation vs. Charity: The compensation of top executives dwarfs the amount of charity care provided. The millions paid to a handful of individuals could fund medical care for thousands of low-income patients.
Public vs. Private Pay: These executive salaries are wildly out of line with public service compensation and are more aligned with Wall Street than with a mission-driven organization.
Key Executive Compensation (2023)
| Marschall Runge | CEO, Michigan Medicine | $1.64M |
| Charles Reuland | COO, Michigan Medicine | $1.16M |
Verdict
University of Michigan Health's executive compensation packages demonstrate a clear priority for enriching its leadership — a stark contradiction to its charitable mission and public service mandate.
Exhibit D
Public Benefit vs. Private Gain
Fair Share Deficit: Despite its massive revenues and tax breaks, University of Michigan Health has a "fair share deficit" of -$92 million, according to the Lown Institute. This means the value of its tax exemptions far exceeds its spending on charity care and community investment.
Revenue-Generating "Charity": Programs like the 340B Drug Pricing Program, which are intended to help low-income patients, have become major revenue streams. Michigan Medicine has 516 contracts with 340B pharmacies, generating significant income from drug discounts that are not fully passed on to patients.
Minimal Charity Care: The Lown Institute's analysis of Michigan hospitals reveals a pattern of providing less in community benefit than they receive in tax breaks. For 340B hospitals in Michigan, charity care averages just 1.66% of patient revenue.
The Fair Share Gap
Verdict
University of Michigan Health masterfully leverages its nonprofit status to maximize private gain, transforming public benefit programs into profit centers while providing a level of charity that pales in comparison to its vast resources and tax advantages.
Exhibit E
The 340B Drug Pricing Program
A Case Study in Profit-Driven "Charity"
A Program Transformed: The 340B Drug Pricing Program, created to provide a financial lifeline to safety-net hospitals serving vulnerable communities, has been transformed by Michigan Medicine into a powerful revenue engine. The program allows eligible hospitals to purchase outpatient drugs at a significant discount, with the expectation that these savings will be used to benefit patients.
Massive Scale, Opaque Benefits: Michigan Medicine's 340B program is vast, with 516 pharmacy contracts. While the organization claims that the savings are "foundational" to its mission, there is little transparency in how these savings translate into direct benefits for low-income patients. The discounts are not directly passed on to patients, and the revenue generated is folded into the health system's massive operating budget.
A Pattern of Exploitation: A report by the Community and Mission-Based Healthcare Institute highlighted how some hospitals exploit the 340B program, generating large profits without a corresponding increase in care for the poor. Michigan Medicine's large number of contract pharmacies and significant revenue from the program raise serious questions about whether the primary beneficiary is the community or the corporation.
Verdict
The 340B program at University of Michigan Health is a prime example of how a well-intentioned public benefit program can be leveraged for institutional profit, with the "charity" label serving as a convenient justification for a lucrative business line.
Final Verdict
University of Michigan Health is not a charity. It is a tax-advantaged, multi-billion-dollar healthcare corporation disguised as a public service institution. It leverages its "nonprofit" and "educational" status to amass vast wealth, enrich its executives, and dominate the healthcare market — all while providing a level of community benefit that is dwarfed by the immense tax breaks it receives.
Evidence Summary
| A | Tax Status | Structural tax immunity since 1817. $1B+ in annual tax breaks for Michigan nonprofits. |
| B | Financial Scale | $8.5B revenue, $35.4B university assets, $233.5M operating surplus. |
| C | Executive Compensation | $1.64M CEO salary. $1.16M COO salary. Wall Street pay, church taxes. |
| D | Public Benefit | -$92M fair share deficit. 1.66% charity care. Tax breaks exceed community benefit. |
| E | 340B Exploitation | 516 pharmacy contracts. Opaque benefit distribution. Revenue engine disguised as charity. |
Continue Reading
Return to the $275B systematic advantage or explore state-level investigations.